Company intelligence / Profile preview

Southern Research

Birmingham, Alabama, United Statessouthernresearch.org ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Southern Research has an extensive legacy of drug discovery and development, including seven FDA-approved cancer drugs. It provides contract research services spanning from basic research to GLP preclinical studies. The institute played a significant role in COVID‑19 research—including vaccine collaborations—and continues to support biotech innovation through its Station 41 incubator.

Therapeutic areas: OtherOncologyRare DiseasesInfectious Diseases
Modalities: small moleculesbiologicsantibody therapeuticsvaccinesdiagnostics
Industry: Academic Hospital/University/Research

Partnerships

Collaborations with academic institutions for COVID‑19 vaccine development and other projects.Partnerships with local biotech startups through the Station 41 incubator.

Beyond the preview

Go deeper on Southern Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Southern Research.

Explore the full profile